Docetaxel, cisplatin, and 5-fluorouracil compared with epirubicin, cisplatin, and 5-fluorouracil regimen for advanced gastric cancer: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Docetaxel, cisplatin, and 5-fluorouracil compared with epirubicin, cisplatin, and 5-fluorouracil regimen for advanced gastric cancer: A systematic review and meta-analysis

Published:2019-03-06 Issue:5 Volume:7 Page:600-615
ISSN:2307-8960
Container-title:World Journal of Clinical Cases
language:
Short-container-title:WJCC

Author:

Li Bo,Chen Lian,Luo Hong-Liang,Yi Feng-Ming,Wei Yi-Ping,Zhang Wen-Xiong

Publisher

Baishideng Publishing Group Inc.

Subject

General Medicine

Reference39 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Advances in the Pharmacological Treatment of Gastro-Oesophageal Cancer

3. Clinical epidemiology of gastric cancer

4. Gastric and gastro-oesophageal cancer therapy

5. Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Docetaxel-Based Neoadjuvant Chemotherapy Followed by En Bloc Resection for Esophageal Adenocarcinoma: A 15-Year Retrospective Analysis from a Regional Upper Gastrointestinal Cancer Network;Annals of Surgical Oncology;2023-12-23

2. Dynamic changes of DNA methylation induced by benzo(a)pyrene in cancer;Genes and Environment;2023-07-01

3. Phase 2 randomized controlled trial of intravenous or intraperitoneal paclitaxel plus mFOLFOX6 vs. mFOLFOX6 as first-line treatment of advanced gastric cancer;Frontiers in Oncology;2022-09-07

4. Treatment Outcome and Safety of the TCX Regimen for Advanced Gastric Cancer: A Prospective Cohort Study;Cancer Management and Research;2022-09

5. Comparison of cisplatin-induced nephrotoxicity between single-dose and split-dose administration to rats;Biomedicine & Pharmacotherapy;2022-03